FDA Gives Approval to Use AIDS Drug to Treat Hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval to the Gilead AIDS drug Viread, to help treat hepatitis B patients. The Gilead AIDS drug is known in its generic form as tenofovir, and has been on the market as an AIDS drug since 2001. Recent studies though have shown that it is very effective in treating people who are living with hepatitis B, helping by controlling the disease. Hepatitis B can be a fatal disease, attacking the liver.

Related Information

• Viread - Another Med to Fight the Battle

• Viread Fact Sheet

• HIV Treatment Regimens